OrthoPediatrics Corp. (NASDAQ:KIDS) Short Interest Update

OrthoPediatrics Corp. (NASDAQ:KIDS) saw a large decline in short interest during the month of January. As of January 31st, there was short interest totalling 826,300 shares, a decline of 9.7% from the January 15th total of 914,900 shares. Based on an average trading volume of 277,800 shares, the short-interest ratio is currently 3.0 days. Approximately 5.1% of the company’s shares are short sold.

OrthoPediatrics Price Performance

NASDAQ KIDS opened at $24.62 on Tuesday. The business’s fifty day moving average price is $24.16 and its 200-day moving average price is $26.22. The stock has a market capitalization of $596.30 million, a price-to-earnings ratio of -20.02 and a beta of 1.14. The company has a debt-to-equity ratio of 0.19, a current ratio of 7.17 and a quick ratio of 3.68. OrthoPediatrics has a 1-year low of $21.02 and a 1-year high of $35.99.

Analyst Upgrades and Downgrades

A number of research analysts have weighed in on the company. Truist Financial reduced their target price on OrthoPediatrics from $28.00 to $25.00 and set a “hold” rating on the stock in a report on Wednesday, December 18th. Needham & Company LLC reiterated a “buy” rating and set a $42.00 target price on shares of OrthoPediatrics in a report on Tuesday, January 14th.

Hedge Funds Weigh In On OrthoPediatrics

A number of institutional investors have recently bought and sold shares of KIDS. Quarry LP bought a new position in shares of OrthoPediatrics in the 3rd quarter valued at about $25,000. International Assets Investment Management LLC lifted its holdings in shares of OrthoPediatrics by 2,610.8% in the 3rd quarter. International Assets Investment Management LLC now owns 1,003 shares of the company’s stock valued at $27,000 after acquiring an additional 966 shares during the last quarter. R Squared Ltd bought a new position in shares of OrthoPediatrics in the 4th quarter valued at about $48,000. KLP Kapitalforvaltning AS bought a new position in shares of OrthoPediatrics in the 4th quarter valued at about $79,000. Finally, BNP Paribas Financial Markets lifted its holdings in shares of OrthoPediatrics by 125.1% in the 3rd quarter. BNP Paribas Financial Markets now owns 3,471 shares of the company’s stock valued at $94,000 after acquiring an additional 1,929 shares during the last quarter. 69.05% of the stock is owned by institutional investors.

About OrthoPediatrics

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.